22.18
Introdução à Hemostasia
A hemostasia é um processo fisiológico complexo que evita o sangramento excessivo quando um vaso sanguíneo é ferido. É crucial para manter a integrida…
A hemostasia é uma série de reações rápidas e defensivas desencadeadas para interromper o sangramento excessivo e promover a cicatrização após uma lesão vascular.
É uma resposta altamente localizada governada por fatores de coagulação e plaquetas que começa apenas no local da lesão.
A lesão ou trauma se instala na fase vascular, onde os vasos sanguíneos se contraem rapidamente para reduzir o fluxo sanguíneo.
A fase plaquetária segue a vasoconstrição, onde o colágeno do revestimento das células endoteliais danificadas inicia a adesão plaquetária.
Essas plaquetas localizadas são ativadas e liberam vários compostos para atrair mais plaquetas, formando um tampão plaquetário solto no local da lesão. Esse processo é denominado agregação plaquetária.
Além disso, as plaquetas também liberam fatores de coagulação envolvidos nas reações da fase final de coagulação.
Os fatores de coagulação convertem a proteína plasmática fibrinogênio em fios de fibrina insolúveis, formando uma malha que solidifica o tampão plaquetário em um coágulo estável.
View the full transcript and gain access to JoVE Core videos
Q1: What happens to blood vessels immediately after an injury?
During the vascular phase, blood vessels quickly constrict in a process called vasoconstriction to reduce blood flow to the injury site. This rapid narrowing minimizes blood loss and is the first defensive response triggered by vascular injury, setting the stage for subsequent hemostasis phases.
Q2: How do platelets respond to a blood vessel injury?
Platelets adhere to exposed collagen from damaged endothelial cells and become activated. They then aggregate at the injury site, releasing compounds that attract additional platelets and clotting factors. This process forms a loose platelet plug that acts as a temporary seal to control bleeding.
Q3: What role do clotting factors play in hemostasis?
Clotting factors, including fibrinogen, are plasma proteins that convert into fibrin strands during the coagulation phase. These insoluble fibrin strands form a meshwork that solidifies the platelet plug into a stable clot, reinforcing the temporary seal and preventing further blood loss.
Q4: Why is hemostasis described as a localized response?
Hemostasis is highly localized because it is triggered only at the injury site and governed by clotting factors and platelets present in the immediate area. This targeted response prevents unnecessary clotting throughout the circulatory system while maintaining blood fluidity elsewhere in the vascular network.
Q5: What is the relationship between platelet aggregation and clot formation?
Platelet aggregation creates an initial loose plug at the injury site. Simultaneously, activated platelets release clotting factors that trigger the coagulation phase, converting fibrinogen to fibrin. This fibrin reinforces the platelet plug, transforming it into a stable, insoluble clot that effectively seals the vessel.
Q6: How does hemostasis maintain blood fluidity within intact vessels?
Hemostasis is a carefully controlled response that occurs only when vascular injury triggers the cascade. Under normal conditions, clotting factors remain inactive in plasma, and platelets circulate without aggregating. This balance ensures blood remains fluid and flows freely through the circulatory system until injury necessitates clot formation.
Q7: What are the three sequential phases of hemostasis?
Hemostasis progresses through three phases: the vascular phase involves vasoconstriction to reduce blood flow; the platelet phase includes platelet adhesion, activation, and aggregation forming a plug; and the coagulation phase converts fibrinogen to fibrin, creating a stable clot that reinforces the platelet plug and prevents further bleeding.